This company listing is no longer active
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
NanoVibronix Inkomsten in het verleden
Verleden criteriumcontroles 0/6
NanoVibronix's earnings have been declining at an average annual rate of -15%, while the Medical Equipment industry saw earnings growing at 4.2% annually. Revenues have been growing at an average rate of 37.5% per year.
Belangrijke informatie
-15.0%
Groei van de winst
-20.9%
Groei van de winst per aandeel
| Medical Equipment Groei van de industrie | 4.3% |
| Inkomstengroei | 37.5% |
| Rendement op eigen vermogen | -168.5% |
| Nettomarge | -724.5% |
| Laatste winstupdate | 31 Dec 2022 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe NanoVibronix geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 31 Dec 22 | 1 | -5 | 5 | 0 |
| 30 Sep 22 | 2 | -6 | 6 | 0 |
| 30 Jun 22 | 2 | -12 | 6 | 0 |
| 31 Mar 22 | 2 | -10 | 6 | 0 |
| 31 Dec 21 | 2 | -14 | 5 | 0 |
| 30 Sep 21 | 1 | -13 | 5 | 0 |
| 30 Jun 21 | 1 | -7 | 5 | 0 |
| 31 Mar 21 | 1 | -8 | 5 | 0 |
| 31 Dec 20 | 1 | -4 | 5 | 0 |
| 30 Sep 20 | 1 | -5 | 4 | 0 |
| 30 Jun 20 | 1 | -4 | 4 | 0 |
| 31 Mar 20 | 1 | -4 | 4 | 0 |
| 31 Dec 19 | 1 | -6 | 5 | 1 |
| 30 Sep 19 | 0 | -6 | 5 | 1 |
| 30 Jun 19 | 0 | -6 | 5 | 1 |
| 31 Mar 19 | 0 | -6 | 5 | 1 |
| 31 Dec 18 | 0 | -4 | 4 | 1 |
| 30 Sep 18 | 0 | -5 | 4 | 1 |
| 30 Jun 18 | 0 | -5 | 3 | 1 |
| 31 Mar 18 | 0 | -6 | 3 | 1 |
| 31 Dec 17 | 0 | -6 | 3 | 1 |
| 30 Sep 17 | 0 | -5 | 2 | 1 |
| 30 Jun 17 | 0 | -4 | 2 | 1 |
| 31 Mar 17 | 0 | -3 | 2 | 1 |
| 31 Dec 16 | 0 | -3 | 2 | 1 |
| 30 Sep 16 | 0 | -2 | 2 | 1 |
| 30 Jun 16 | 0 | -3 | 1 | 0 |
Kwaliteitswinsten: 56R0 is currently unprofitable.
Groeiende winstmarge: 56R0 is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 56R0 is unprofitable, and losses have increased over the past 5 years at a rate of 15% per year.
Versnelling van de groei: Unable to compare 56R0's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: 56R0 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.3%).
Rendement op eigen vermogen
Hoge ROE: 56R0 has a negative Return on Equity (-168.51%), as it is currently unprofitable.